News

Umoja CEO Robby Greenfield says monetizing Bitcoin should be as simple as buying stocks on Robinhood.

Dialysis provider DaVita Inc. (NYSE:DVA) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $3.29 billion. Its non-GAAP profit of $2.24 per share was 4.3% above analysts’ consensus estimates.

Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 32.8% year on year to $39.22 million. Its non-GAAP loss of $0.20 per share was 15.5% below analysts’ consensus estimates.

Construction management software maker Procore (NYSE:PCOR) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 16.2% year on year to $302 million. The company expects next quarter’s revenue to be around $302 million, close to analysts’ estimates. Its non-GAAP profit of $0.01 per share was 91.2% below analysts’ consensus estimates.

Acoustic component provider Knowles (NYSE:KN) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 33.8% year on year to $142.5 million. Next quarter’s revenue guidance of $129 million underwhelmed, coming in 5.5% below analysts’ estimates. Its non-GAAP profit of $0.27 per share was 4.4% below analysts’ consensus estimates.

Shares of Palantir Technologies hit a record closing price again Thursday and are up more than 50% to start 2025, growth that analysts attribute in part to the stock’s popularity with retail investors.

Online learning platform Udemy (NASDAQ:UDMY) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 5.5% year on year to $199.9 million. On the other hand, next quarter’s revenue guidance of $197 million was less impressive, coming in 2.7% below analysts’ estimates. Its non-GAAP profit of $0.10 per share was 53.4% above analysts’ consensus estimates.